Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Boryung Bio Pharma is a leading South Korean biotechnology company specializing in the development and manufacturing of vaccines, specialized pharmaceuticals, and diagnostic kits. As a key subsidiary of the Boryung Group, the company operates advanced production facilities, including a dedicated vaccine plant in Jincheon, and provides a comprehensive range of immunization products such as flu, hepatitis, and DTaP vaccines. Beyond its core vaccine business, Boryung Bio Pharma is active in the fields of blood products, genetic testing services, and neonatal screening. The company is currently expanding its portfolio into biopharmaceuticals and high-value diagnostic services to strengthen its position in the global healthcare market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Boryung Bio.